01

Who we are

02

MyGenera^TM

03

Product Pipeline

04

Research & Innovation

05

Partnership

06

News & Media

News & Media

25/02/2026

Global Scientific Collaborations and International Development: The Network Supporting Biogenera’s Growth

News

23/12/2025

Year-end update and key milestones for 2025

Corporate Update, News

12/12/2025

BGA002 Orphan Drug Designations: Neuroblastoma and Rhabdomyosarcoma

News

26/11/2025

BGA002: From Industrial Scale to the Clinic — The New Chapter for Biogenera

Corporate Update, News

10/11/2025

Biogenera: Update on Progress Toward the Clinical Phase of BGA002 and Pipeline Development

Corporate Update, News

07/11/2025

Biogenera to Attend BIO-Europe 2025: Europe’s Leading Biotech Partnering Event

Evento, News

English